Acquired Postpartum Hemophilia A Presentation of Severe Hematuria: A Case Report

Main Article Content

Wafaa M. Abdelghany


BACKGROUND: Acquired hemophilia A (AHA) is a rare, severe bleeding disorder caused by the development of autoantibodies against FVIII that may be idiopathic or secondary to medical conditions. Postpartum AHA can occur as early as 1–4 months after delivery or as late as 1-year postpartum.

CASE REPORT: A 20-year-old female presented with vaginal bleeding 20 days after delivery, then ecchymotic patches developed 2 months later, followed by hematuria 2 months after that. Laboratory investigation revealed isolated, prolonged partial thromboplastin time that was not corrected by mixing 50:50 with fresh normal plasma. FVIII activity was markedly deficient, with a high titer of immediate-acting FVIII inhibitor antibodies.

CONCLUSION: The case was diagnosed as postpartum AHA with a good response to the combined steroids and cyclophosphamide treatment.


Download data is not yet available.

Plum Analytics

Article Details

How to Cite
Abdelghany WM. Acquired Postpartum Hemophilia A Presentation of Severe Hematuria: A Case Report. SEE J Immunol [Internet]. 2023 Aug. 24 [cited 2024 Apr. 16];6(1):80-2. Available from:
Clinical Immunology


Qian L, Ge H, Hu P, Zhu N, Chen J, Shen J, et al. Pregnancy-related acquired hemophilia A initially manifesting as pleural hemorrhage: A case report. Medicine (Baltimore). 2019;98(3):e14119. MD.0000000000014119 PMid:30653138 DOI:

Namburi S. Acquired Haemophilia: Practice Essentials, Background, Pathophysiology. https://ww.emedicine.medscape. com/article/211186 [Last accessed on 2023 Mar 17].

Hofbauer CJ, Whelan SF, Hirschler M, Allacher P, Horling FM, Lawo JP, et al. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans. Blood. 2015;125(7):1180-8. PMid:25515962 DOI:

Napolitano M, Raso S, Cariccio MR, Carlisi M, Mancuso S, Lipari MG, et al. Acquired Hemophilia A as early manifestation of multiple myeloma: A case report. J Hematol Mult Myeloma. 2017;2:1006.

Karish MA, Hanbali A, Al Zahrani H, Al Sahli R. Postpartum-acquired hemophilia: A challenging disease to manage. J Appl Hematol. 2017;8(2):75-8. DOI:

Karakuş V, Celik M, Soysal D, Payzın B. Postpartum acquired hemophilia factor VIII inhibitors and response to therapy. Turk J Haematol. 2012;29(2):197-8. PMid:24744658 DOI:

Collins P, Baudo F, Knoebl P, Levesque H, Nemes L, Pellegrini F. Immunosuppression for acquired hemophilia A: results from the European acquired haemophilia registry (EACH2). Blood. 2012;120(1):47-55. PMid:22517903 DOI:

Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired haemophilia A: A concise review. Am J Hematol. 2005;80(1):55-63. PMid:16138334 DOI:

Kumar N, Rajpal S, Ahluwalia J, Bose S, Uppal V, Varma N, et al. Acquired hemophilia A: Experience of a tertiary care institute from north India. Indian J Hematol Blood Transfus. 2018;34(3):524-9. PMid:30127565 DOI:

Huth-K¨uhne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Lévesque H, et al. Internationa recommendations on the diagnosis and treatment of patient with acquired hemophilia A. Haematologica. 2009;94(4):566-75. PMid:19336751 DOI:

Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): Results from the GTH-AH 01/2010 study. Blood. 2015;125(7):1091-7. PMid:25525118 DOI:

Palangasinghe DR, Gamage VN, Bodinayake CK, Mohotti MG. Severe anaemia and multiple ecchymoses in a postpartum female due to acquired haemophilia A. Galle Med J. 2017;22(1):33-4. DOI:

Dally N, Kashlikov M. Pregnancy related acquired hemophilia A. Harefuah. 2019;158(3):184-6. PMid:30916507

Mahendra A, Padiolleau-Lefevre S, Kaveri SV, Lacroix- Desmazes S. Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A? Br J Haematol. 2012;156(1):3-12. PMid:21988190 DOI:

Mo L, Bao GC. Acquired factor VIII deficiency: Two case reports and a review of literature. Exp Hematol Oncol. 2017;6:8. PMid:28352491 DOI:

Knight C, Dano AM, Kennedy-Martin T. Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors. Adv Ther. 2009;26(1):68-88. PMid:19156372 DOI:

Liu Y, Ruan X, Lei P, Shang B, Zhu, Chen S, et al. Acquired hemophilia A: A retrospective multicenter analysis of 42 patients. Clin Appl Thromb Hemost. 2023;29:10760296221151165. PMid:36653966 DOI:

Lee JJ, Chung IJ, Park MR, Yang DH, Cho SH, Ryang DW, et al. Acquired hemophilia successfully treated with oral immunosuppressive therapy. Korean J Intern Med. 2000;15(2):135-7. PMid:10992727 DOI: